The Causes and Consequences of DNA Damage and Chromosomal Instability Induced by Human Papillomavirus.

DNA damage response alternative end-joining chromosomal instability (CIN) human papillomavirus (HPV) mitosis radiation

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
25 Apr 2024
Historique:
received: 31 03 2024
revised: 18 04 2024
accepted: 20 04 2024
medline: 11 5 2024
pubmed: 11 5 2024
entrez: 11 5 2024
Statut: epublish

Résumé

High-risk human papillomaviruses (HPVs) are the main cause of cervical, oropharyngeal, and anogenital cancers, which are all treated with definitive chemoradiation therapy when locally advanced. HPV proteins are known to exploit the host DNA damage response to enable viral replication and the epithelial differentiation protocol. This has far-reaching consequences for the host genome, as the DNA damage response is critical for the maintenance of genomic stability. HPV+ cells therefore have increased DNA damage, leading to widespread genomic instability, a hallmark of cancer, which can contribute to tumorigenesis. Following transformation, high-risk HPV oncoproteins induce chromosomal instability, or chromosome missegregation during mitosis, which is associated with a further increase in DNA damage, particularly due to micronuclei and double-strand break formation. Thus, HPV induces significant DNA damage and activation of the DNA damage response in multiple contexts, which likely affects radiation sensitivity and efficacy. Here, we review how HPV activates the DNA damage response, how it induces chromosome missegregation and micronuclei formation, and discuss how these factors may affect radiation response. Understanding how HPV affects the DNA damage response in the context of radiation therapy may help determine potential mechanisms to improve therapeutic response.

Identifiants

pubmed: 38730612
pii: cancers16091662
doi: 10.3390/cancers16091662
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : NIH HHS
ID : 1K08CA256166-01A1
Pays : United States

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

Kathryn M Jones (KM)

Department of Human Oncology, University of Wisconsin, Madison, WI 53705, USA.

Ava Bryan (A)

Department of Human Oncology, University of Wisconsin, Madison, WI 53705, USA.

Emily McCunn (E)

Department of Human Oncology, University of Wisconsin, Madison, WI 53705, USA.

Pate E Lantz (PE)

Department of Human Oncology, University of Wisconsin, Madison, WI 53705, USA.

Hunter Blalock (H)

Department of Human Oncology, University of Wisconsin, Madison, WI 53705, USA.
University of Wisconsin School of Medicine and Public Health, University of Wisconsin, Madison, WI 53705, USA.

Isabel C Ojeda (IC)

Department of Human Oncology, University of Wisconsin, Madison, WI 53705, USA.
University of Wisconsin School of Medicine and Public Health, University of Wisconsin, Madison, WI 53705, USA.

Kavi Mehta (K)

Department of Comparative Biosciences, University of Wisconsin, Madison, WI 53705, USA.
Carbone Cancer Center, University of Wisconsin, Madison, WI 53705, USA.

Pippa F Cosper (PF)

Department of Human Oncology, University of Wisconsin, Madison, WI 53705, USA.
Carbone Cancer Center, University of Wisconsin, Madison, WI 53705, USA.

Classifications MeSH